Impact of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Renal Function in Patient with Heart Failure
Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor is a recently introduced oral agent to treat renal anemia, but its clinical implications on renal functioning in patients with heart failure remains unknown. We studied an 81-year-old man with heart failure with mildly reduced ejection f...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2021-12-01
|
| coleção: | Journal of Cardiovascular Development and Disease |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/2308-3425/8/12/189 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|